Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress
Ngày 09/07/2020 09:29 | Lượt xem: 861

Paragonix Technologies presented new clinical data at the American Transplant Congress (ATC) on the successful use of the Paragonix SherpaPak cardiac transport system for high-risk donor hearts at the Medical University of Vienna (Vienna, Austria), a leading European heart transplant centre.

A press release from the company details that Andreas Zuckermann (director of cardiac transplantation, Medical University of Vienna) presented a series of eight non-consecutive heart transplant cases involving donor hearts with extended ischaemic times that were preserved using the Paragonix SherpaPak cardiac transport system. Donor risk levels were calculated using the Eurotransplant (ET) donor risk score and recipient risks were calculated using the IMPACT score. For this series of cases, the median ET score was 18.4 (representing a 40% probability of donor heart acceptance), the median IMPACT score was 10 (representing a 19% expected mortality at one year) and the median ischaemic time was 4.8 hours.

According to the company statement, the authors concluded that the Paragonix SherpaPak cardiac transport system provided consistent temperature control during transportation of the grafts and can be successfully used with long ischaemic times and high-risk donor hearts.

Bill Edelman, chairman & CEO for Paragonix, comments in the press release: “We are delighted to see the continued release of clinical research data regarding the Paragonix SherpaPak cardiac transport system. This data expands on past publications of clinically complex heart transplant situations using the Paragonix SherpaPak cardiac transport system.”

The company says that Paragonix SherpaPak systems incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. Paragonix SherpaPak cardiac transport system is the only commercially available US Fodd and Drug Administration (FDA) cleared and CE marked transport device for heart preservation. Paragonix is also developing transport devices for the lung, pancreas, kidney and liver designed to improve donor organ quality and extend donor organ preservation time.

Source CardiovascularNews

Duc Tin Clinic

Print Chia sẽ qua facebook bài: Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress Chia sẽ qua google bài: Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress Chia sẽ qua twitter bài: Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress Chia sẽ qua MySpace bài: Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress Chia sẽ qua LinkedIn bài: Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress Chia sẽ qua stumbleupon bài: Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress Chia sẽ qua icio bài: Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress Chia sẽ qua digg bài: Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress Chia sẽ qua yahoo bài: Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress Chia sẽ qua yahoo bài: Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress Chia sẽ qua yahoo bài: Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress Chia sẽ qua yahoo bài: Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP